121 related articles for article (PubMed ID: 10493940)
1. CD87-positive tumor cells in bone marrow aspirates identified by confocal laser scanning fluorescence microscopy.
Noack F; Helmecke D; Rosenberg R; Thorban S; Nekarda H; Fink U; Lewald J; Stich M; Schutze K; Harbeck N; Magdolen V; Graeff H; Schmitt M
Int J Oncol; 1999 Oct; 15(4):617-23. PubMed ID: 10493940
[TBL] [Abstract][Full Text] [Related]
2. A new approach to phenotyping disseminated tumor cells: methodological advances and clinical implications.
Noack F; Schmitt M; Bauer J; Helmecke D; Krüger W; Thorban S; Sandherr M; Kuhn W; Graeff H; Harbeck N
Int J Biol Markers; 2000; 15(1):100-4. PubMed ID: 10763150
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow-disseminated tumor cells in patients with carcinoma of the esophagus or cardia.
Bonavina L; Soligo D; Quirici N; Bossolasco P; Cesana B; Lembertenghi Deliliers G; Peracchia A
Surgery; 2001 Jan; 129(1):15-22. PubMed ID: 11150029
[TBL] [Abstract][Full Text] [Related]
4. Minimal residual disease in gastric cancer: evidence of an independent prognostic relevance of urokinase receptor expression by disseminated tumor cells in the bone marrow.
Heiss MM; Simon EH; Beyer BC; Gruetzner KU; Tarabichi A; Babic R; Schildberg FW; Allgayer H
J Clin Oncol; 2002 Apr; 20(8):2005-16. PubMed ID: 11956259
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical phenotyping of disseminated tumor cells in bone marrow by uPA receptor and CK18: investigation of sensitivity and specificity of an immunogold/alkaline phosphatase double staining protocol.
Allgayer H; Heiss MM; Riesenberg R; Babic R; Jauch KW; Schildberg FW
J Histochem Cytochem; 1997 Feb; 45(2):203-12. PubMed ID: 9016310
[TBL] [Abstract][Full Text] [Related]
6. Clinical value of extended biologic staging by bone marrow micrometastases and tumor-associated proteases in gastric cancer.
Heiss MM; Allgayer H; Gruetzner KU; Babic R; Jauch KW; Schildberg FW
Ann Surg; 1997 Dec; 226(6):736-44; discussion 744-5. PubMed ID: 9409572
[TBL] [Abstract][Full Text] [Related]
7. Urokinase receptor localization in breast cancer and benign lesions assessed by in situ hybridization and immunohistochemistry.
Hildenbrand R; Glienke W; Magdolen V; Graeff H; Stutte HJ; Schmitt M
Histochem Cell Biol; 1998 Jul; 110(1):27-32. PubMed ID: 9681686
[TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical detection of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma.
Thorban S; Roder JD; Nekarda H; Funk A; Siewert JR; Pantel K
J Natl Cancer Inst; 1996 Sep; 88(17):1222-7. PubMed ID: 8780632
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow involvement in esophageal cancer patients who underwent surgical resection.
Bagheri R; Maddah G; Saedi HS; Sadeghian MH; Roodbari S
Eur J Cardiothorac Surg; 2011 Aug; 40(2):343-6. PubMed ID: 21345693
[TBL] [Abstract][Full Text] [Related]
10. Urokinase plasminogen activator receptor (uPA-R): one potential characteristic of metastatic phenotypes in minimal residual tumor disease.
Allgayer H; Heiss MM; Riesenberg R; Grützner KU; Tarabichi A; Babic R; Schildberg FW
Cancer Res; 1997 Apr; 57(7):1394-9. PubMed ID: 9102229
[TBL] [Abstract][Full Text] [Related]
11. Expression and functional role of urokinase-type plasminogen activator receptor in normal and acute leukaemic cells.
Lanza F; Castoldi GL; Castagnari B; Todd RF; Moretti S; Spisani S; Latorraca A; Focarile E; Roberti MG; Traniello S
Br J Haematol; 1998 Oct; 103(1):110-23. PubMed ID: 9792297
[TBL] [Abstract][Full Text] [Related]
12. CD87 (urokinase-type plasminogen activator receptor), function and pathology in hematological disorders: a review.
Béné MC; Castoldi G; Knapp W; Rigolin GM; Escribano L; Lemez P; Ludwig WD; Matutes E; Orfao A; Lanza F; van't Veer M;
Leukemia; 2004 Mar; 18(3):394-400. PubMed ID: 14671631
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of disseminated tumor cells in the bone marrow of breast cancer patients by the Thomsen-Friedenreich tumor antigen.
Schindlbeck C; Jeschke U; Schulze S; Karsten U; Janni W; Rack B; Sommer H; Friese K
Histochem Cell Biol; 2005 Jun; 123(6):631-7. PubMed ID: 15889266
[TBL] [Abstract][Full Text] [Related]
14. The urokinase-receptor (CD87) is expressed in cells of the megakaryoblastic lineage.
Wohn KD; Kanse SM; Deutsch V; Schmidt T; Eldor A; Preissner KT
Thromb Haemost; 1997 Mar; 77(3):540-7. PubMed ID: 9066008
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of bone marrow micrometastases in patients with gastric cancer.
Jauch KW; Heiss MM; Gruetzner U; Funke I; Pantel K; Babic R; Eissner HJ; Riethmueller G; Schildberg FW
J Clin Oncol; 1996 Jun; 14(6):1810-7. PubMed ID: 8656249
[TBL] [Abstract][Full Text] [Related]
16. cDNA transfection of amino-terminal fragment of urokinase efficiently inhibits cancer cell invasion and metastasis.
Zhu F; Jia S; Xing G; Gao L; Zhang L; He F
DNA Cell Biol; 2001 May; 20(5):297-305. PubMed ID: 11410166
[TBL] [Abstract][Full Text] [Related]
17. Real-time quantitative PCR determination of urokinase-type plasminogen activator receptor (uPAR) expression of isolated micrometastatic cells from bone marrow of breast cancer patients.
Pierga JY; Bonneton C; Magdelénat H; Vincent-Salomon A; Nos C; Boudou E; Pouillart P; Thiery JP; de Cremoux P
Int J Cancer; 2005 Mar; 114(2):291-8. PubMed ID: 15543615
[TBL] [Abstract][Full Text] [Related]
18. Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87).
Krüger A; Soeltl R; Lutz V; Wilhelm OG; Magdolen V; Rojo EE; Hantzopoulos PA; Graeff H; Gänsbacher B; Schmitt M
Cancer Gene Ther; 2000 Feb; 7(2):292-9. PubMed ID: 10770639
[TBL] [Abstract][Full Text] [Related]
19. Expression and cellular localization of the urokinase-type plasminogen activator and its receptor in human hepatocellular carcinoma.
Dubuisson L; Monvoisin A; Nielsen BS; Le Bail B; Bioulac-Sage P; Rosenbaum J
J Pathol; 2000 Feb; 190(2):190-5. PubMed ID: 10657018
[TBL] [Abstract][Full Text] [Related]
20. Relationship between urokinase-type plasminogen receptor, interleukin-8 gene expression and clinicopathological features in gastric cancer.
Lee KH; Bae SH; Lee JL; Hyun MS; Kim SH; Song SK; Kim HS
Oncology; 2004; 66(3):210-7. PubMed ID: 15218312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
